STRUCTURE-ACTIVITY RELATIONSHIPS OF ALKYLATING AGENTS IN CANCER CHEMOTHERAPY
- 1 October 1969
- journal article
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 163 (2 Biologic) , 1006-1025
- https://doi.org/10.1111/j.1749-6632.1969.tb24916.x
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Synthesis of Potential Dual Antagonists IIIJournal of Pharmaceutical Sciences, 1965
- Studies on the mechanism of action of cyclophosphamide and AB-132 with the aid of radioprotective agentsLife Sciences, 1964
- 643. Cytotoxic compounds. Part VI. Some N′-[α-(acylamino)-acyl]-NN-di-2′-chloroethyl-p-phenylenediaminesJournal of the Chemical Society, 1964
- Consideration of chemical reaction mechanisms in relationship to the biological action of “dual antagonists”Biochemical Pharmacology, 1962
- Use of AB-103 (a “dual antagonist”) in the treatment of bronchogenic carcinomaCancer, 1961
- Clinical Experience with AB-100Southern Medical Journal, 1961
- ‘Dual Antagonists’; Alkyl N-(bis-(ethylenimido)phosphoro)-carbamates; a New Series of Anti-Tumour AgentsNature, 1959
- FUTURE EXPERIMENTAL APPROACHESAnnals of the New York Academy of Sciences, 1958
- THE STATUS OF ALKYLATING AGENTS IN CLINICAL CANCER CHEMOTHERAPYAnnals of the New York Academy of Sciences, 1958
- Cytochemical and Cytological Studies of Drug ActionNature, 1952